Autoimmune disease Clinical Trials in Murrieta, CA
As of June 2026, 5 paid clinical trials are recruiting for Autoimmune disease in Murrieta, California. Autoimmune disease research covers a broad spectrum of immune-modulating therapies — JAK inhibitors, biologics, T-cell modulators, and tolerance-inducing agents — across rheumatologic, dermatologic, neurologic, and GI conditions. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
5 clinical trials for Autoimmune disease
·Clear filters·↓ Download CSVAn Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
About research studies in Murrieta
Murrieta has approximately 28 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Murrieta
Researchers run research studies in Murrieta, CA at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Esperanza Clinical | Agitation Associated With Alzheimer's Disease Dementia, Alzheimer Disease, Early Parkinson Disease (Early PD) | 3 |
| United Medical Doctors | Crohn's Disease, Moderately to Severely Active Crohn Disease, Ulcerative Colitis | 3 |
| Urology Center of Southern California | High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer, Non-muscle-invasive Bladder Cancer | 3 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| LoBue Laser and Eye Medical Center | Dry Eye Disease, Dry Eye Disease (DED) | 2 |
| Tri Valley Urology Medical Group | Urodynamics, Urologic Diseases, Urothelial Carcinoma | 2 |
| Valkyrie Clinical Trials Murrieta | Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of Head and Neck | 2 |
| Inland Empire Gastroenterology | Crohn's Disease, Ulcerative Colitis | 1 |
| Loma Linda University Medical Center | Lumbar Spinal Stenosis | 1 |
| Loma Linda University Professional Building - Murrieta | Sleep Apnea Syndromes in Children, Sleep Apnea, Obstructive, Sleep-Disordered Breathing | 1 |
| Rady Children's NICU at Rancho Springs Medical Center | Delivery Room Resuscitation, Implementation Research, Infant, Newborn | 1 |
| Rancho Springs Medical Center Rady NICU | Neonatal Respiratory Failure | 1 |
| Research Site 152 | Urinary Tract Infections | 1 |
| Tri Valley Urology | Benign Prostatic Hyperplasia, Overactive Bladder, Prostate Cancer | 1 |
| Tri Valley Urology - Murrieta | FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration | 1 |
| United Clinical Research Institute | Crohn's Disease, Ulcerative Colitis | 1 |
| United Medical Doctors - Murrieta | Metabolic Dysfunction-Associated Steatotic Liver Disease | 1 |
| United Medical Doctors CA - Site Number: 8400044 | Ulcerative Colitis | 1 |
| United Medical Doctors CA-Site Number: 8400044 | Crohn's Disease | 1 |
| University Surgery Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Murrieta (2026)
Recruiting trials in Murrieta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (9 active studies)
- A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer · Phase 3 · Janssen Research & Development, LLC
- Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer · Phase 3 · Summit Therapeutics
Neurology & pain (3 active studies)
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease · Phase 2 · Neuron23 Inc.
- Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy · Loma Linda University
Pediatric (3 active studies)
- Supraglottic Airway for Resuscitation Trial · Children's Hospital of Philadelphia
- Flow and Grow - The Ideal Time to Wean CPAP Off In Extremely Low Birth Weight Infants · University of California, San Diego
Eye & vision (2 active studies)
- A Clinical Study Evaluating Licaminlimab for Dry Eye Disease · Phase 2, Phase 3 · Oculis
- A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease · Phase 2 · Bausch & Lomb Incorporated
Common conditions studied in Murrieta
- Crohn's Disease (3 active studies). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Ulcerative Colitis (3 active studies). Ulcerative colitis trials examine biologic therapies, S1P receptor modulators, and oral small molecules for steroid-sparing remission.
- Agitation Associated With Alzheimer's Disease Dementia (1 active study). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
- Alzheimer Disease (1 active study). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Benign Prostatic Hyperplasia (1 active study). Recruiting Benign Prostatic Hyperplasia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Carcinoma, Non-Small-Cell Lung (1 active study). Recruiting Carcinoma, Non-Small-Cell Lung studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Murrieta
- Janssen Research & Development, LLC
- Sanofi
- Summit Therapeutics
- Takeda
- Abivax S.A.
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Murrieta. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Murrieta
Hipa.ai aggregates every recruiting study in Murrieta from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Murrieta?
There are approximately 28 recruiting clinical trials in Murrieta, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Murrieta pay participants?
Most recruiting trials in Murrieta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Murrieta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Murrieta?
The most common conditions under active study in Murrieta include Crohn's Disease (3), Ulcerative Colitis (3), Agitation Associated With Alzheimer's Disease Dementia (1), Alzheimer Disease (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Murrieta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Murrieta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Murrieta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Murrieta?
Recruiting research sites in Murrieta include Esperanza Clinical, United Medical Doctors, Urology Center of Southern California, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Murrieta right now?
The largest active categories in Murrieta are Cancer & tumors (9), Neurology & pain (3), Pediatric (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.